AngioSoma appoints new chief executive officer


AngioSoma has appointed Ken Stephenson as chief executive officer, board member, and president of the company.

Having set up and worked with interventional radiologists and cardiologists’ practices, Stephenson’s focus will be to bridge the gap between the AngioSoma’s technology, current standard-of-care treatments, and reimbursement by Medicare, Medicaid, and private insurance companies to these medical professionals, a company release states.

Alexanderia Blankenship will now be chief operating officer and executive vice president.